SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-028533
Filing Date
2023-05-10
Accepted
2023-05-10 17:47:37
Documents
1
Period of Report
2023-05-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4162
  Complete submission text file 0001209191-23-028533.txt   5570
Mailing Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612
Business Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612 (858) 283-0280
Reneo Pharmaceuticals, Inc. (Issuer) CIK: 0001637715 (see all company filings)

IRS No.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O RIVERVEST VENTURE PARTNERS 101 SOUTH HANLEY RD., STE 1850 ST. LOUIS MO 63105
Business Address
O'Donnell Niall (Reporting) CIK: 0001780235 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40315 | Film No.: 23907981